BioRestorative Therapies (BRTX) Non-cash Items (2010 - 2019)
BioRestorative Therapies' (BRTX) quarterly Non-cash Items came in at $3.3 million in Q3 2019, up 112.83% YoY from $1.6 million in Q3 2018, and up 22.12% on a QoQ basis from $2.7 million in Q2 2019.
BioRestorative Therapies (BRTX) Non-cash Items (2010 - 2019) Analysis & Trends
BioRestorative Therapies (BRTX) has 10 years of Non-cash Items data on file, last reported at $3.3 million in Q3 2019.
- Quarterly Non-cash Items rose 112.83% year-over-year to $3.3 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $10.0 million (up 69.73% YoY) and the FY2018 annual result came in at $7.4 million, up 32.6% from the prior year.
- Non-cash Items improved to $3.3 million in Q3 2019, from $2.7 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $3.3 million in Q3 2019 to a low of $499897.0 in Q4 2017.
- A 5-year average of $1.5 million and a median of $1.5 million in 2017 frame the typical range for Non-cash Items.
- Annual changes were most pronounced in 2016 — Non-cash Items slumped 51.82% — and 2018, when it jumped 303.56%.
- Tracing BRTX's Non-cash Items over 5 years: stood at $2.1 million in 2015, then tumbled by 51.82% to $995033.0 in 2016, then slumped by 49.76% to $499897.0 in 2017, then jumped by 303.56% to $2.0 million in 2018, then jumped by 65.88% to $3.3 million in 2019.
- The last three Non-cash Items figures came in at $3.3 million (Q3 2019), $2.7 million (Q2 2019), and $1.9 million (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 3.35 Mn |
| Sep 30, 2019 | 3.35 Mn |
| Jun 30, 2019 | 2.74 Mn |
| Jun 30, 2019 | 2.74 Mn |
| Mar 31, 2019 | 1.90 Mn |
| Mar 31, 2019 | 1.90 Mn |
| Dec 31, 2018 | 2.02 Mn |
| Dec 31, 2018 | 2.02 Mn |
| Sep 30, 2018 | 1.57 Mn |
| Sep 30, 2018 | 1.57 Mn |
| Jun 30, 2018 | 2.47 Mn |
| Jun 30, 2018 | 2.47 Mn |
| Mar 31, 2018 | 1.35 Mn |
| Mar 31, 2018 | 1.35 Mn |
| Dec 31, 2017 | 499,897.00 |
| Dec 31, 2017 | 499,897.00 |
| Sep 30, 2017 | 1.54 Mn |
| Sep 30, 2017 | 1.54 Mn |
| Jun 30, 2017 | 1.98 Mn |
| Jun 30, 2017 | 1.98 Mn |